- GSK3008348
-
- $1.00 / 1KG
-
2019-12-26
- CAS:1629249-33-7
- Min. Order: 1KG
- Purity: 97%-99.9%
- Supply Ability: 100kg
|
| GSK3008348 Basic information |
Product Name: | GSK3008348 | Synonyms: | GSK3008348;GSK 3008348;GSK-3008348;1-Pyrrolidinebutanoic acid, β-[3-(3,5-dimethyl-1H-pyrazol-1-yl)phenyl]-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-, (βS,3R)-;1-Pyrrolidinebutanoicacid,β-[3-(3,5-dimethyl-1H-pyrazol-1-yl)phenyl]-3-[2-(1,5,6,7-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-,(βS,3R)-;(S)-3-(3-(3,5-dimethyl-1H-pyrazol-1-yl)phenyl)-4-((R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic acid | CAS: | 1629249-33-7 | MF: | C29H37N5O2 | MW: | 487.65 | EINECS: | | Product Categories: | | Mol File: | 1629249-33-7.mol | |
| GSK3008348 Chemical Properties |
Boiling point | 716.2±60.0 °C(Predicted) | density | 1.26±0.1 g/cm3(Predicted) | pka | 4.22±0.10(Predicted) |
| GSK3008348 Usage And Synthesis |
Uses | GSK3008348 (CAS# 1629249-33-7) is a pharmaceutically acceptable salt thereof for use in combination therapy of interstitial lung disease. |
| GSK3008348 Preparation Products And Raw materials |
|